Azura Ophthalmics is taking a unique pharmaceutical approach to ocular surface disease by developing the first ophthalmic keratolytic for the treatment of lid margin diseases such as Meibomian Gland Dysfunction (MGD), blepharitis, and contact lens discomfort.
Read more ↓
Tired of ads? Enjoy an ad-free experience by signing up.
Unlock unlimited company data
Already a subscriber? Log in.
Our subscriber community includes professionals from these companies:
Similar companies
Tired of ads? Enjoy an ad-free experience by signing up.